Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Orthopaedic Management of Spasticity.
Clobetasol and Halcinonide Act as Smoothened Agonists to Promote Myelin Gene Expression and RxRγ Receptor Activation.
[Low back pain: atypical presentation of multiple sclerosis.]
A profile of childhood neuropathies at a university hospital in Oman.
The Role of Microglia and Matrix Metalloproteinases Involvement in Neuroinflammation and Gliomas.
Progressive multifocal leukoencephalopathy in multiple sclerosis.
Tai Chi Chuan in Medicine and Health Promotion.
Cerebrospinal fluid light and heavy neurofilaments in neuromyelitis optica.
Multiple sclerosis: Drug-enhanced remyelination in a multiple sclerosis model.
Immunoablation of cells expressing the NG2 chondroitin sulphate proteoglycan.
Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
Comparison of human adult stem cells from adipose tissue and bone marrow in the treatment of experimental autoimmune encephalomyelitis.
Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: Results from a longitudinal study.
Therapeutic promises of 2-methoxyestradiol and its drug disposition challenges.
Concentration of 25(OH)D3 and calcium and phosphorus metabolism in patients suffering from relapsing-remitting multiple sclerosis. A pilot study.
The Evi5 family in cellular physiology and pathology.
Education protects against cognitive changes associated with multiple sclerosis.
Assessing relapse in multiple sclerosis questionnaire: results of a pilot study.
Register-based incidence of multiple sclerosis in Brittany (north-western France), 2000-2001.
Neuromyelitis optica spectrum disorder presenting with repeated hypersomnia due to involvement of the hypothalamus and hypothalamus-amygdala linkage.
Acute Demyelinating Encephalomyelitis in a Neonate Secondary to Dengue Infection.
Piroxicam confer neuroprotection in Cerebral Ischemia by inhibiting Cyclooxygenases, Acid- Sensing Ion Channel-1a and Aquaporin-4: an in silico comparison with Aspirin and Nimesulide.
A Case of Acute Disseminated Encephalomyelitis in a Middle-Aged Adult.
Teriflunomide - a new oral agent for multiple sclerosis treatment.
Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: Relation to brain findings and clinical disability.
Pages
« first
‹ previous
…
546
547
548
549
550
551
552
553
554
…
next ›
last »